Holdings

Octagon Capital Advisors LP

As of Sep 30, 2026, Octagon Capital Advisors LP reported 24 positions worth US$732M. Largest: Dianthus Therapeutics, Inc., Abivax SA and Definium Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Dianthus Therapeutics, Inc.1.69MUS$149M−155KSep 30, 2026
Abivax SA993KUS$98.3Mno changeSep 30, 2026
Definium Therapeutics, Inc.2.51MUS$95.6M−439KSep 30, 2026
Cogent Biosciences, Inc.2.35MUS$75.2Mno changeSep 30, 2026
ArriVent BioPharma, Inc.2.14MUS$64.8M+170KSep 30, 2026
Taysha Gene Therapies, Inc.9.69MUS$47.2Mno changeSep 30, 2026
Obsidian Therapeutics, Inc.2.41MUS$33.2MnewSep 30, 2026
Kymera Therapeutics, Inc.205KUS$22.9M−105KSep 30, 2026
Disc Medicine, Inc.270KUS$17.7Mno changeSep 30, 2026
Tango Therapeutics, Inc.630KUS$15.7MnewSep 30, 2026